| Primary |
| Breast Cancer |
24.2% |
| Prostate Cancer |
14.8% |
| Non-small Cell Lung Cancer |
10.0% |
| Premedication |
6.3% |
| Prophylaxis |
5.8% |
| Hypertension |
4.0% |
| Her-2 Positive Breast Cancer |
3.9% |
| Product Used For Unknown Indication |
3.4% |
| Non-small Cell Lung Cancer Stage Iv |
3.3% |
| Prostate Cancer Metastatic |
3.2% |
| Drug Use For Unknown Indication |
3.0% |
| Pain |
2.6% |
| Gastric Cancer |
2.3% |
| Nausea |
2.2% |
| Breast Cancer Metastatic |
2.1% |
| Head And Neck Cancer |
2.1% |
| Chemotherapy |
1.9% |
| Squamous Cell Carcinoma |
1.8% |
| Squamous Cell Carcinoma Of Head And Neck |
1.5% |
| Non-small Cell Lung Cancer Metastatic |
1.4% |
|
| Vomiting |
12.9% |
| Neutropenia |
8.9% |
| Death |
8.4% |
| Pyrexia |
7.2% |
| Febrile Neutropenia |
5.9% |
| Sepsis |
5.4% |
| Interstitial Lung Disease |
4.8% |
| Pneumonia |
4.8% |
| Respiratory Failure |
4.2% |
| Dyspnoea |
3.7% |
| Pulmonary Embolism |
3.7% |
| Hyponatraemia |
3.6% |
| Renal Failure |
3.6% |
| Septic Shock |
3.6% |
| Renal Failure Acute |
3.5% |
| White Blood Cell Count Decreased |
3.4% |
| Thrombocytopenia |
3.3% |
| Diarrhoea |
3.2% |
| Sudden Death |
2.9% |
| Urinary Retention |
2.9% |
|
| Secondary |
| Breast Cancer |
34.8% |
| Drug Use For Unknown Indication |
11.7% |
| Prostate Cancer |
9.5% |
| Breast Cancer Metastatic |
5.5% |
| Non-small Cell Lung Cancer |
5.1% |
| Product Used For Unknown Indication |
4.8% |
| Head And Neck Cancer |
3.7% |
| Prophylaxis |
3.1% |
| Hypertension |
2.9% |
| Premedication |
2.8% |
| Gastric Cancer |
2.3% |
| Pain |
2.1% |
| Prostate Cancer Metastatic |
2.1% |
| Oesophageal Carcinoma |
1.7% |
| Her-2 Positive Breast Cancer |
1.7% |
| Nausea |
1.5% |
| Lung Neoplasm Malignant |
1.4% |
| Chemotherapy |
1.2% |
| Prophylaxis Of Nausea And Vomiting |
1.1% |
| Metastatic Gastric Cancer |
0.9% |
|
| Vomiting |
13.9% |
| Neutropenia |
10.5% |
| Febrile Neutropenia |
9.6% |
| Pyrexia |
7.9% |
| Thrombocytopenia |
5.2% |
| Sepsis |
5.1% |
| Pneumonia |
5.0% |
| Rash |
5.0% |
| Death |
4.4% |
| Syncope |
4.0% |
| Pulmonary Embolism |
3.7% |
| White Blood Cell Count Decreased |
3.6% |
| Stomatitis |
3.3% |
| Dyspnoea |
3.2% |
| Mucosal Inflammation |
3.1% |
| Diarrhoea |
3.0% |
| Dehydration |
2.5% |
| Urinary Tract Infection |
2.4% |
| Renal Failure |
2.4% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.3% |
|
| Concomitant |
| Breast Cancer |
22.6% |
| Breast Cancer Metastatic |
10.9% |
| Metastases To Bone |
9.6% |
| Prostate Cancer |
8.4% |
| Drug Use For Unknown Indication |
7.6% |
| Product Used For Unknown Indication |
7.0% |
| Chemotherapy |
7.0% |
| Non-small Cell Lung Cancer |
5.7% |
| Prophylaxis |
2.5% |
| Prostate Cancer Metastatic |
2.1% |
| Adenocarcinoma Pancreas |
2.0% |
| Gastric Cancer |
2.0% |
| Pancreatic Carcinoma Metastatic |
1.8% |
| Premedication |
1.8% |
| Neoplasm Malignant |
1.7% |
| Lung Adenocarcinoma |
1.6% |
| Prostate Cancer Stage Iv |
1.6% |
| Pain |
1.5% |
| Lung Neoplasm Malignant |
1.4% |
| Hypertension |
1.3% |
|
| Febrile Neutropenia |
8.7% |
| Tooth Extraction |
8.3% |
| Neutropenia |
7.2% |
| Vomiting |
6.1% |
| Osteonecrosis |
5.9% |
| Pyrexia |
5.6% |
| Osteonecrosis Of Jaw |
5.5% |
| Disease Progression |
5.3% |
| Pulmonary Embolism |
4.8% |
| Weight Decreased |
4.7% |
| White Blood Cell Count Increased |
4.7% |
| White Blood Cell Count Decreased |
4.5% |
| Pain |
4.3% |
| Death |
4.0% |
| Hospitalisation |
4.0% |
| Sepsis |
3.7% |
| Prostate Cancer |
3.4% |
| Thrombocytopenia |
3.4% |
| Pleural Effusion |
3.0% |
| Bone Pain |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
23.3% |
| Breast Cancer Metastatic |
11.0% |
| Prophylaxis Against Hiv Infection |
11.0% |
| Breast Cancer |
9.8% |
| Hiv Infection |
9.2% |
| Prophylaxis |
5.5% |
| Drug Therapy |
4.9% |
| Prophylaxis Of Nausea And Vomiting |
4.9% |
| Squamous Cell Carcinoma |
3.7% |
| Chemotherapy |
3.1% |
| Epilepsy |
2.5% |
| Anesthesia |
1.8% |
| Antiemetic Supportive Care |
1.8% |
| Antiretroviral Therapy |
1.8% |
| Hiv Test Positive |
1.8% |
| Kaposi's Sarcoma |
1.2% |
| Atrial Fibrillation |
0.6% |
| Cancer Pain |
0.6% |
| Lung Neoplasm Malignant |
0.6% |
| Musculoskeletal Chest Pain |
0.6% |
|
| Skin Exfoliation |
21.6% |
| Vomiting |
18.9% |
| Extrasystoles |
5.4% |
| Mucosal Inflammation |
5.4% |
| Pseudomembranous Colitis |
5.4% |
| Pyrexia |
5.4% |
| Bradycardia |
2.7% |
| Drug Interaction |
2.7% |
| Febrile Neutropenia |
2.7% |
| Musculoskeletal Pain |
2.7% |
| Neutropenia |
2.7% |
| Oral Candidiasis |
2.7% |
| Partial Seizures |
2.7% |
| Prothrombin Time Ratio Increased |
2.7% |
| Rash |
2.7% |
| Skin Disorder |
2.7% |
| Skin Lesion |
2.7% |
| Stevens-johnson Syndrome |
2.7% |
| Supraventricular Tachycardia |
2.7% |
| Upper Gastrointestinal Haemorrhage |
2.7% |
|
